Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Rectal Infiltration of Exparel for Analgesic Benefit Following Hemorrhoidectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* patients undergoing hemorrhoidectomy for grade 3 or 4 hemorrhoids who are English-speaking patients, 21-65 yr of age, ASA physical status I-III, BMI\<30~Exclusion Criteria:~* contraindications to administration of local anesthesia (e.g., local anesthetic allergy), difficult airway (Mallampati\>2), psychiatric or cognitive disorders, pregnancy , and history of substance abuse or chronic opioid use

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Exparel (Type: ACTIVE_COMPARATOR): 266mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL)
- Bupivacaine HCl with epinephrine (Type: ACTIVE_COMPARATOR): 75mg/30mL 0.25% Bupivacaine HCl with epinephrine
- Normal Saline (Type: PLACEBO_COMPARATOR): 30mL Normal Saline

Based on this trial design, predict the completion outcome and termination type (if applicable).